Repro Med Systems, Inc.(以 KORU Medical Systems 名义经营)在美国及国际上主要面向门诊输液市场设计、制造和销售便携式医疗设备。公司总部位于纽约州切斯特。
财务指标
营业收入
2026-06-30
$1204.54万
2026-03-31
$1176.46万
2025-12-31
$1089.53万
2025-09-30
$1040.22万
营业支出
2026-06-30
$721.92万
2026-03-31
$789.87万
2025-12-31
$736.45万
2025-09-30
$713.22万
净利润
2026-06-30
$25.24万
2026-03-31
-$80.7万
2025-12-31
-$48.68万
2025-09-30
-$77.79万
净利润率
2026-06-30
2.09%
2026-03-31
-6.86%
2025-12-31
-4.46%
2025-09-30
-7.47%
每股收益
2026-06-30
$0.01
2026-03-31
$-0.01
2025-12-31
$0.01
2025-09-30
$-0.01
息税折旧摊销前利润
2026-06-30
$46.82万
2026-03-31
-$60.95万
2025-12-31
-$30.29万
2025-09-30
-$57.36万
有效税率
2026-06-30
2.24%
2026-03-31
--
2025-12-31
-0.97%
2025-09-30
0.01%
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$1204.54万
$1176.46万
$1089.53万
$1040.22万
营业支出
$721.92万
$789.87万
$736.45万
$713.22万
净利润
$25.24万
-$80.7万
-$48.68万
-$77.79万
净利润率
2.09%
-6.86%
-4.46%
-7.47%
每股收益
$0.01
$-0.01
$0.01
$-0.01
息税折旧摊销前利润
$46.82万
-$60.95万
-$30.29万
-$57.36万
有效税率
2.24%
--
-0.97%
0.01%
常见问题
KRMD, which trades under the ticker KRMD, represents REPRO-MED Systems, Inc., commonly known as Repro Med Systems. The company is a medical device manufacturer that focuses on the development, manufacture, and sale of specialty infusion systems and related products. Its primary products are used for the delivery of medications and fluids in various clinical settings, including home infusion and hospital care. KRMD operates within the U.S. healthcare sector and serves a niche market of patients and healthcare providers.
The current price of KRMD stock fluctuates during market hours. To obtain the most accurate and up-to-date price, please refer to the live quote displayed on this page. The price you see reflects the latest trade and may change frequently based on supply and demand. For historical or intraday price information, you can also check the stock chart provided on the page.
Volatility measures how much KRMD's stock price moves over a given period. Small-cap medical device stocks like KRMD can experience significant price swings due to factors such as product announcements, regulatory decisions, or changes in financial performance. The stock's beta, which compares its volatility to the broader market, is available on the page. For specific volatility metrics, please refer to the latest KRMD data displayed on this page.
Evaluating KRMD's valuation involves reviewing metrics such as price-to-sales (P/S), price-to-earnings (P/E), and enterprise value-to-EBITDA, alongside comparisons to peers in the medical device industry. Because KRMD may not be consistently profitable, P/S or EV/Sales can be more informative. Additionally, assess the company's revenue growth, gross margins, and cash flow trends. All relevant valuation ratios are typically available on the stock detail page to help you form a comprehensive view.
KRMD is listed on the NASDAQ stock exchange, where it can be bought and sold through a licensed brokerage account. Trading occurs during regular market hours, typically from 9:30 a.m. to 4:00 p.m. Eastern Time, Monday through Friday, excluding market holidays. Some brokers also offer extended-hours trading sessions. To trade KRMD, you need to place an order through your broker's platform, specifying the number of shares and order type.
KRMD currently does not pay dividends to its shareholders. The company retains its earnings to reinvest in its business operations, research and development, and potential growth initiatives. As a result, there is no dividend yield or dividend history associated with KRMD. Investors seeking income may need to look at other stocks that distribute dividends, while those focused on growth may consider KRMD's reinvestment strategy as part of their evaluation.